Edition:
India

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
1:30am IST
Change (% chg)

$-0.00 (-1.12%)
Prev Close
$0.22
Open
$0.22
Day's High
$0.23
Day's Low
$0.22
Volume
106,744
Avg. Vol
119,975
52-wk High
$3.43
52-wk Low
$0.22

Latest Key Developments (Source: Significant Developments)

Immune Pharma Presents Positive Results From Phase 2 Trial Of Bullous Pemphigoid Treatment
Tuesday, 15 May 2018 

May 15 (Reuters) - Immune Pharmaceuticals Inc ::IMMUNE PHARMACEUTICALS PRESENTS UPDATED POSITIVE RESULTS FROM PHASE 2 TRIAL OF BERTILIMUMAB IN BULLOUS PEMPHIGOID.IMMUNE PHARMACEUTICALS INC - POSITIVE DATA SUPPORT COMPANY'S PLANS TO COMMENCE PIVOTAL REGISTRATION STUDY IN 2019.IMMUNE PHARMACEUTICALS INC - RESULTS FROM ALL SUBJECTS CONFIRM "EXCELLENT" SAFETY AND TOLERABILITY.  Full Article

Immune Pharmaceuticals reports Q3 results
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Immune Pharmaceuticals Inc :Immune Pharmaceuticals announces third quarter 2017 financial results and provides a corporate update.Immune Pharmaceuticals Inc - ‍Company recorded no revenue for three-month periods ended September 30, 2017 and 2016​.  Full Article

Immune Pharmac prices $18 mln public offering
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Immune Pharmaceuticals Inc :Immune Pharmaceuticals Inc announces pricing of $18,000,000 public offering of convertible preferred stock and warrants.Immune Pharmaceuticals Inc - ‍offering will be comprised of units, priced at a public offering price of $1,000 per unit​.  Full Article

Immune Pharmaceuticals Q2 loss per share $0.13
Tuesday, 16 Aug 2016 

Immune Pharmaceuticals Inc : Q2 loss per share $0.13 .Immune Pharmaceuticals provides business and research and development update and announces second quarter 2016 financial results.  Full Article

Immune Pharmaceuticals offers up to 3.2 mln shares
Saturday, 30 Jul 2016 

Immune Pharmaceuticals Inc :Says it is offering up to 3.2 million shares of co's common stock to institutional investors - SEC filing.  Full Article

Immune pharmaceuticals to form pain,neurology spin off company around AmiKet
Tuesday, 19 Jul 2016 

Immune Pharmaceuticals Inc : Immune pharmaceuticals to form pain and neurology spin off company around AmiKet . Says parties have agreed to a target closing date of september 15, 2016 . NPT plans to make first tranche of its investment into new subsidiary upon closing based on pre-agreed terms . Parties have agreed to a target closing date of september 15, 2016 . According to amended agreement immune will form a pain-neurology subsidiary, which will own AmiKet intellectual property .Says entered into an amended agreement with NPT, a syndicate of experienced healthcare investors.  Full Article

BRIEF-Immune Pharmaceuticals Says Board Will Not Pursue Spin-Off Of Cytovia Unit

* IMMUNE PHARMACEUTICALS PROVIDES UPDATE ON PLANS FOR ONCOLOGY SUBSIDIARY, CYTOVIA, INC.